Department of Otorhinolaryngology, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong Province, China.
PLoS One. 2013 Apr 4;8(4):e60157. doi: 10.1371/journal.pone.0060157. Print 2013.
To investigate the most important factors affecting the prognosis of the patients with squamous cell carcinoma (SCC) of the larynx.
Based on the clinical and follow-up data, 205 patients with SCC of the larynx receiving total laryngectomy, partial laryngectomy, or CO2 laser surgery in GuangDong General Hospital were retrospectively analyzed. A survival analysis was performed by the Kaplan-Meier method and a multivariable analysis of prognostic factors was carried out using the Cox proportional hazard model.
Subtypes of carcinoma included 69.8% glottic and 30.2% supraglottic. Most patients were in N0 stage (77.6%), and 22.4% patients were in N1∼N3 stage. Over half of the patients were in T1∼T2 stage (55.1%), 20.0% in T3, and 24.9% in T4. Mean follow-up duration was 49.2 months. The survival rates 1, 2, and 3 years after the surgery were 99.0%, 91.7%, and 81.5%, respectively. The survival rate for those patients with clinical stage IV was significantly lower than for those with clinical stage I and II (p<0.001 and p = 0.013, respectively). The disease-free progression rates 1, 2, and 3 years after the surgery were 83.9%, 74.6%, and 71.2%, respectively. Futhermore, those patients with a Charlson score of 1 to 2 and ≥3 had higher risk of mortality than those with a Charlson score of 0 (hazard ratios of 1.8 and 2.41 p = 0.042 and p = 0.008). Multivariable analysis revealed that clinical stage, surgical margin, and comorbidity were significantly associated with both mortality and disease-free progression.
The surgical resection margin, clinical stage, and comorbidity were independent factors affecting the laryngeal cancer prognosis. The survival rates were lower for patients with advanced laryngeal cancer, positive surgical margins, or severe comorbidity, suggesting the importance of early diagnosis, early treatment, negative surgical margins, and conditions of comorbidity.
探讨影响喉鳞状细胞癌(SCC)患者预后的最重要因素。
基于临床和随访资料,回顾性分析了在广东总医院接受全喉切除术、部分喉切除术或 CO2 激光手术的 205 例喉 SCC 患者。采用 Kaplan-Meier 法进行生存分析,采用 Cox 比例风险模型进行预后因素的多变量分析。
癌的亚型包括 69.8%的声门型和 30.2%的声门上型。大多数患者处于 N0 期(77.6%),22.4%的患者处于 N1~N3 期。超过一半的患者处于 T1~T2 期(55.1%),20.0%的患者处于 T3 期,24.9%的患者处于 T4 期。平均随访时间为 49.2 个月。手术后 1、2、3 年的生存率分别为 99.0%、91.7%和 81.5%。临床分期为 IV 期的患者生存率明显低于 I 期和 II 期(p<0.001 和 p=0.013)。手术后 1、2、3 年的无疾病进展率分别为 83.9%、74.6%和 71.2%。此外,Charlson 评分为 1~2 和≥3 的患者的死亡风险高于 Charlson 评分为 0 的患者(危险比分别为 1.8 和 2.41,p=0.042 和 p=0.008)。多变量分析显示,临床分期、手术切缘和合并症与死亡率和无疾病进展均显著相关。
手术切除边缘、临床分期和合并症是影响喉癌预后的独立因素。晚期喉癌、阳性手术切缘或严重合并症的患者生存率较低,提示早期诊断、早期治疗、阴性手术切缘和合并症的状况的重要性。